Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01477528 · ClinicalTrials.gov registry record
Study of Reduced Anti-coagulation/Anti-platelet Therapy in Patients With the HeartMate II Left Ventricular Assist System (LVAS) (TRACE)
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 201
- Enrollment target
NCT01477528 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 201 participants.
The verdict
NCT01477528 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 201 participants
- Enrollment target
Study Summary
The purpose of this observational study is to obtain multi-center data on HeartMate II (HMII) patients managed with reduced anticoagulation or anti-platelet regimes, and the incidence of thrombotic and bleeding adverse events associated with these regimes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2011-11 |
| Est. Completion | 2015-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01477528
The ClinicalTrials.gov registry entry for NCT01477528 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 201 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01477528 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01477528 about?
NCT01477528 is a clinical study titled "Study of Reduced Anti-coagulation/Anti-platelet Therapy in Patients With the HeartMate II Left Ventricular Assist System (LVAS) (TRACE)". The purpose of this observational study is to obtain multi-center data on HeartMate II (HMII) patients managed with reduced anticoagulation or anti-platelet regimes, and the incidence of thrombotic and bleeding adverse events associated with these regimes.
What is the current status of trial NCT01477528?
This trial is currently completed. The enrollment target is 201 participants. The study started on 2011-11. Estimated completion is 2015-08.
Who is sponsoring clinical trial NCT01477528?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.